Docket Alarm

The Federal Trade Commission announced on April 22 that a federal court in Florida temporarily shut down what the agency describes as a nationwide health-care impersonation scheme. According to the FTC, the operation allegedly posed as government entities and major insurance carriers to deceive consumers seeking health coverage or related services.

The matter is notable

Skechers U.S.A., Inc. has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening PTAB docket IPR2026-00343 on April 24, 2026. At this stage, the filing appears to be a newly instituted challenge record centered on a patent dispute involving Skechers, with practitioners likely watching for the patent owner’s preliminary

The Justice Department’s first public settlement under its Civil Rights Fraud Initiative is an important signal for companies that do business with the federal government. According to a recent litigation summary, IBM agreed to pay roughly $17 million to resolve allegations that certain DEI-related practices conflicted with anti-discrimination obligations tied to federal contracts, creating potential

Friday’s legal landscape reflects a familiar but high-stakes mix of appellate rulings, enforcement activity, regulatory change, and headline criminal matters. For legal professionals, the significance is less in any single development than in the broader pattern: courts and agencies continue to test the limits of corporate liability, administrative power, and procedural strategy.

First, major court

Today’s legal news cycle underscores how quickly risk can shift across courts, agencies, and prosecutors’ offices. For litigators and legal departments, the significance is not just in any single headline, but in the broader pattern: major legal developments are continuing to emerge simultaneously in constitutional litigation, regulatory enforcement, and criminal law, creating a more complex

The Supreme Court’s Thursday activity put a spotlight on a question with outsized consequences for federal sentencing practice: how much discretion district courts have to identify “extraordinary and compelling reasons” for compassionate release under 18 U.S.C. § 3582(c)(1)(A). While compassionate-release disputes once occupied a relatively narrow corner of criminal practice, they have become a major

A federal court has ordered a central operator in an alleged timeshare-exit scheme to pay $140 million and permanently barred him from the industry, according to the Federal Trade Commission. The ruling marks a significant consumer-protection result in a sector that has drawn sustained regulatory scrutiny over claims that distressed timeshare owners were promised relief

The April 2026 securities docket underscores a familiar but important reality for market participants: SEC enforcement remains broad, active, and strategically significant. Recent developments include the continuing federal court proceedings in SEC v. Musk, a $2.4 million settlement in an SEC fraud case involving a venture capital fund executive and related firms, and a steady

The Department of Justice has announced that IBM will pay approximately $17.1 million to resolve allegations that the company violated anti-discrimination obligations tied to its federal contracts. According to DOJ, IBM’s diversity, equity, and inclusion practices allegedly discriminated on the basis of race, color, national origin, or sex, creating potential False Claims Act exposure when

A cluster of major Justice Department developments reported this week underscores a familiar but increasingly urgent reality for companies and counsel: federal enforcement risk remains high across multiple fronts, and the government continues to pair aggressive charging decisions with public messaging aimed at deterrence.

While the specific matters span different industries and statutes, the common

The SEC has settled insider-trading charges against Weizheng Zeng in an administrative proceeding arising from the acquisition of Chimerix, Inc. by Jazz Pharmaceuticals plc. In SEC v. Weizheng Zeng (File No. 3-22627), the agency alleged that Zeng traded Chimerix stock while participating in due diligence work connected to Jazz’s acquisition of the company, before

The Department of Justice’s Antitrust Division, alongside the U.S. Attorney’s Office for the Southern District of New York, has filed a civil antitrust suit against New York-Presbyterian, alleging the hospital system used contractual restrictions that limited access to lower-cost healthcare options. The case, United States Of America v. New York Presbyterian Hospital, is an